BGNE Chart
See on advanced chart >
About
Beigene, Ltd. established on October 28, 2010,is principally engaged in biopharmaceutical business. The Company is mainly engaged in the research and development, production and sales of innovative molecularly targeted and immuno-oncology drugs for the...
Read More
- HighlightA Chinese developer of innovative, molecularly targeted and immuno-oncology drugs to treat cancer
- ExchangeNASDAQ
- Listing Date02/03/2016
- Established Date10/28/2010
- Full-time Employees10,600
- AddressNo. 30 Science Park Road Zhong-Guan-Cun Life Science Park Changping District Beijing PRC
- Tel86-10-58958058
- Website
- Fiscal Year End Date12/31
- Security TypeAmerican Depositary Receipt (Common Stock)
Industry
Pharmaceuticals